تقرير سوق علاج سرطان الرئة ذو الخلايا الصغيرة (SCLC) | الحجم والمشاركة والتوقعات المستقبلية 2031

Publication Month : Dec 2023

  • Report Code : TIPRE00034730
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[تقرير بحثي] من المتوقع أن ينمو حجم سوق علاج سرطان الرئة ذو الخلايا الصغيرة من 4,480.85 مليون دولار أمريكي في عام 2022 إلى 9,173.60 مليون دولار أمريكي بحلول عام 2030؛ من المقدر أن يسجل السوق معدل نمو سنوي مركب قدره 9.4٪ من عام 2022 إلى عام 2030.

إن ارتفاع معدل انتشار SCLC وتوافر العلاجات والعلاج المركب لسوق علاج سرطان الرئة ذو الخلايا الصغيرة هي العوامل الجديرة بالملاحظة التي تدفع SCLC نمو سوق العلاج يعد إطلاق المنتجات والموافقات السريعة على المنتجات أيضًا من العوامل الرئيسية المسؤولة عن توفير فرص السوق المربحة خلال الفترة 2020-2030.

يعد سرطان الرئة ذو الخلايا الصغيرة (SCLC) شكلاً عدوانيًا من سرطان الرئة يتميز بنمو سريع وغير منضبط لبعض أنواع السرطان. الخلايا في الرئتين. عامل الخطر الرئيسي لـ SCLC هو استهلاك التبغ والتدخين، وتختلف الأعراض من شخص لآخر. يتم تقسيم SCLC إلى مراحل رئيسية، مثل المرض في مرحلة محدودة ومرض في مرحلة واسعة النطاق. يتم علاج الأفراد المصابين بـ SCLC في كثير من الأحيان بالعلاج الكيميائي والعلاج الإشعاعي، وفي حالة السرطان في مرحلة مبكرة، قد يوصى بإجراء عملية جراحية.

محركات النمو:

ارتفاع معدل انتشار SCLC و توفر العلاجات

وفقًا لتقرير شركة Genentech, Inc. 2023، يمثل SCLC ما يقرب من 13% من جميع حالات سرطان الرئة التي يصعب علاجها. ولذلك، فإن SCLC هو النوع الأكثر عدوانية من سرطان الرئة، مع معدل البقاء على قيد الحياة لمدة 5 سنوات. الخيارات العلاجية الحالية لـ SCLC محدودة، وهناك حاجة غير ملباة لعلاجات جديدة وفعالة لتحسين البقاء على قيد الحياة. على سبيل المثال، يعد العلاج الكيميائي المعتمد على البلاتين (CT) هو الدعامة الأساسية الموصى بها للعلاج. كما أن أدوية العلاج الكيميائي المركبة مثل "سيسبلاستين" و"كاربوبلاستين" هي أكثر الأدوية الموصى باستخدامها مع "إيتوبوسيد" لعلاج SCLC.

يكشف تقرير المعهد الوطني للسرطان أن SCLC يمثل ما يقرب من 15% من سرطانات القصبات الهوائية. ومع ذلك، فقد انخفض إجمالي معدل الإصابة بـ SCLC في الولايات المتحدة خلال العقود القليلة الماضية حيث استجاب المرضى بشكل جيد للعلاج الكيميائي. على سبيل المثال، أدى الإشعاع الصدري أيضًا إلى تحسين نتائج الرعاية الصحية على المدى الطويل للمرضى. لذلك، يعد ارتفاع معدل انتشار SCLC بين السكان وتوافر علاجات محددة للعلاج من العوامل الرئيسية المسؤولة عن النمو المؤثر لسوق SCLC العالمي خلال الفترة المتوقعة 2020-2030.

الرؤى الإستراتيجية
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the small cell lung cancer (SCLC) treatment market?

Small cell lung cancer (SCLC) is an aggressive form of lung cancer characterized by a rapid and uncontrolled growth of certain cells in the lungs. The primary risk factor of SCLC is the consumption of tobacco and smoking, with symptoms varying from person to person. The SCLC is broken down into main stages, such as limited-stage disease and extensive-stage disease. The SCLC-affected individuals are more often treated with chemotherapy and radiation therapy, and in the case of early-stage cancer, surgery may be recommended.

What are the driving factors for the small cell lung cancer (SCLC) treatment market across the globe?

Rising prevalence of SCLC and the availability of therapeutics and combination therapy for the small cell lung cancer treatment market are the factor responsible for the overall market growth.

Which treatment segment led the small cell lung cancer (SCLC) treatment market?

Based on treatment, the chemotherapy segment took the forefront lead in the small cell lung cancer (SCLC) treatment market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

Which stage segment held the largest revenue (US$ Mn) in the small cell lung cancer (SCLC) treatment market?

The extensive stage segment dominated the global small cell lung cancer (SCLC) treatment market and accounted for the largest revenue in 2022.

Who are the key players in the small cell lung cancer (SCLC) treatment market?

F. Hoffmann-La Roche, Bristol Myers Squibb, AstraZeneca, Jazz Pharmaceuticals plc, Merck KgaA, Dr. Reddy's Laboratories, Inc., GlaxoSmithKline (GSK), Pfizer, Regeneron, and Janssen, and among others are among the leading companies operating in the small cell lung cancer (SCLC) treatment market.

The List of Companies - Small Cell Lung Cancer (SCLC) Treatment Market

  1. F. Hoffmann-La Roche
  2. Bristol Myers Squibb
  3. AstraZeneca
  4. Jazz Pharmaceuticals plc
  5. Merck KgaA
  6. Dr. Reddy's Laboratories, Inc.
  7. GlaxoSmithKline (GSK)
  8. Pfizer
  9. Regeneron
  10. Janssen

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports